RecruitingNCT06033274

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment: the TRIPLACE Registry

Sponsor

Montefiore Medical Center

Enrollment

800 participants

Start Date

Oct 5, 2023

Study Type

OBSERVATIONAL

Conditions

Tricuspid Regurgitation

Summary

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcatheter Tricuspid Valve Replacement for people with tricuspid regurgitation. The study is currently recruiting participants at 21 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscatheter Tricuspid Valve Replacement

All patients undergoing Transcatheter Tricuspid Valve Replacement for native tricuspid valve disease

Locations(31)

Arizona Heart Hospital (Biltmore Cardiology)

Phoenix, Arizona, United States

Ascension Via Christi

Wichita, Kansas, United States

Hackensack University Medical Center

Hackensack, New Jersey, United States

Columbia University Irving Medical Center

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

The Christ Hospital

Cincinnati, Ohio, United States

Cleveland Clinic

Cleveland, Ohio, United States

Providence St. Vincent Medical Center

Portland, Oregon, United States

Oregon Health & Science University

Portland, Oregon, United States

St. Paul's Hospital

Vancouver, British Columbia, Canada

St Michael's Hospital, University of Toronto

Toronto, Ontario, Canada

Montréal Heart Institute (MHI)

Montreal, Quebec, Canada

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada

Québec, Quebec, Canada

Rigshospitalet, Copenhagen University Hospital

Copenhagen, Capital Region, Denmark

Clinique Pasteur Toulouse

Toulouse, Haute-Garonne, France

Centre Hospitalier Universitaire de Lille

Lille, Hauts-de-France, France

Hospital Center University De Lille (CHU Lille)

Lille, Hauts-de-France, France

Chu De Bordeaux - Haut-Lévêque Hospital

Bordeaux, Pessac, France

Medical Clinic and Polyclinic, University Hospital of Munich (LMU Klinikum)

Munich, Bavaria, Germany

Cardiovascular Center (CVC) Frankfurt, Division of Cardiology

Frankfurt am Main, Hesse, Germany

University of Duisberg-Essen, West German Heart and Vascular Centre

Essen, North Rhine-Westphalia, Germany

University Heart Center, Schleswig-Holstein University

Lübeck, Schleswig-Holstein, Germany

Heart and Diabetes Centre, North Rhine-Westphalia (NRW), Ruhr-University

Bad Oeynhausen, Germany

Heart Center Cologne, University of Cologne

Cologne, Germany

University Heart and Vascular Center, Department of Cardiology

Hamburg, Germany

San Raffaele University Hospital

Milan, Lombardy, Italy

Centro Cardiologico Monzino IRCCS

Milan, Lombardy, Italy

University Hospital Alvaro Cunqueiro (CHUVI)

Vigo, Pontevedra, Spain

Hospital Clínico Universitario de Valladolid

Valladolid, Spain

University Hospital Basel

Basel, Canton of Basel-City, Switzerland

HerzZentrum Hirslanden Zürich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06033274

Related Trials

Transcatheter Tricuspid Valve Replacement Using the Lux-Valve Plus System

NCT06714500

Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation

NCT070423601 location

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

NCT0409714579 locations

3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device

NCT07793916

Comparing the Effects of Newer Pacemakers and Their Effects on the Heart and Valve Function in the Short-term.

NCT07534917